FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090810 [Registered on: 14/07/2025] Trial Registered Prospectively
Last Modified On: 11/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparative study of nalbuphine versus dexmedetomidine as adjuvant to 0.75% hyperbaric ropivacaine in patients undergoing lower limb surgeries under spinal anaesthesia 
Scientific Title of Study   COMPARATIVE STUDY OF NALBUPHINE VS DEXMEDETOMIDINE AS ADJUVANT TO 0.75% HYPERBARIC ROPIVACAINE IN PATIENTS UNDERGOING LOWER LIMB SURGERIES UNDER SPINAL ANAESTHESIA 
Trial Acronym  NADIR Trial 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Saima Z 
Designation  Postgraduate Student 
Affiliation  Bangalore Medical College and Research Institute 
Address  Department of Anaesthesiology, Bangalore Medical College and Research Institute, K.R. Road, Fort

Bangalore
KARNATAKA
560002
India 
Phone  08825588415  
Fax    
Email  saimazaheer89@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Manjunatha S M 
Designation  Assistant Professor 
Affiliation  Bangalore Medical College and Research Institute 
Address  Department of Anaesthesiology, Bangalore Medical College and Research Institute, K.R. Road, Fort

Bangalore
KARNATAKA
560002
India 
Phone  9958811408  
Fax    
Email  someshwaram18@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Saima Z 
Designation  Postgraduate Student 
Affiliation  Bangalore Medical College and Research Institute 
Address  Department of Anaesthesiology, Bangalore Medical College and Research Institute, K.R. Road, Fort

Bangalore
KARNATAKA
560002
India 
Phone  08825588415  
Fax    
Email  saimazaheer89@gmail.com  
 
Source of Monetary or Material Support  
Bangalore Medical College and Research Institute 
 
Primary Sponsor  
Name  Bangalore Medical College and Research Institute 
Address  Department of Anaesthesiology, Bangalore Medical College and Research Institute, K.R. Road, Fort, Bengaluru – 560002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Saima Z  Bangalore Medical College and Research Institute  Department of Anaesthesiology, Bangalore Medical College and Research Institute, K.R. Road, Fort
Bangalore
KARNATAKA 
08825588415

saimazaheer89@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
InstitutionalEthicsCommittee, Bangalore Medical College and Research Institute  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 3||Administration,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Inj. Dexmedetomidine 5 mcg  Intrathecal injection of 5 mcg Dexmedetomidine as an adjuvant to 0.75% hyperbaric Ropivacaine.Patients will be observed postoperatively for 6 hours to assess duration of analgesia. 
Intervention  Inj. Nalbuphine 0.5 mg  Intrathecal injection of 0.5 mg Nalbuphine as an adjuvant to 0.75% hyperbaric Ropivacaine.Patients will be observed postoperatively for 6 hours to assess duration of analgesia and related parameters. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.ASA physical status I and II
2. Patients aged 18 to 65 years
3. Elective lower limb surgeries under spinal anaesthesia
4. Written informed consent obtained 
 
ExclusionCriteria 
Details  1.Allergy to study drugs
2. Coagulopathy or anticoagulant therapy
3. Severe hepatic or renal or cardiac diseases
4. Local infection at injection site
5. Neurological deficits or spine deformities
6. Pregnancy or lactation
7. Refusal to participate 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 
Duration of effective analgesia (time from intrathecal injection to first request for rescue analgesia)  At time of first request for rescue analgesia, up to 6 hours post intrathecal injection 
 
Secondary Outcome  
Outcome  TimePoints 
Onset of sensory blockade  From intrathecal injection to loss of pinprick sensation at T12 dermatome

 
Onset and duration of motor blockade  Time to achieve Bromage score 3 and duration until return to score 0 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   01/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a prospective randomized controlled trial to compare the efficacy of intrathecal Nalbuphine and Dexmedetomidine as adjuvants to 0.75% hyperbaric Ropivacaine in patients undergoing lower limb surgeries under spinal anaesthesia. The study aims to evaluate duration of effective analgesia, onset and duration of sensory and motor block, hemodynamic parameter, incidence of adverse effects. A total of 60 adult patients will be enrolled and randomized into two groups.  
Close